Harvard Bioscience Long Term Debt 2010-2023 | HBIO

Harvard Bioscience long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
Harvard Bioscience Annual Long Term Debt
(Millions of US $)
2023 $31
2022 $43
2021 $45
2020 $46
2019 $47
2018 $55
2017 $9
2016 $11
2015 $16
2014 $16
2013 $20
2012 $13
2011 $16
2010 $18
2009 $13
Harvard Bioscience Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $31
2023-09-30 $35
2023-06-30 $38
2023-03-31 $41
2022-12-31 $43
2022-09-30 $47
2022-06-30 $46
2022-03-31 $46
2021-12-31 $45
2021-09-30 $43
2021-06-30 $41
2021-03-31 $42
2020-12-31 $46
2020-09-30 $41
2020-06-30 $41
2020-03-31 $46
2019-12-31 $47
2019-09-30 $52
2019-06-30 $52
2019-03-31 $54
2018-12-31 $55
2018-09-30 $59
2018-06-30 $60
2018-03-31 $62
2017-12-31 $9
2017-09-30 $10
2017-06-30 $10
2017-03-31 $11
2016-12-31 $11
2016-09-30 $13
2016-06-30 $14
2016-03-31 $15
2015-12-31 $16
2015-09-30 $15
2015-06-30 $16
2015-03-31 $17
2014-12-31 $16
2014-09-30 $18
2014-06-30 $17
2014-03-31 $19
2013-12-31 $20
2013-09-30 $21
2013-06-30 $21
2013-03-31 $12
2012-12-31 $13
2012-09-30 $15
2012-06-30 $16
2012-03-31 $17
2011-12-31 $16
2011-09-30 $16
2011-06-30 $17
2011-03-31 $17
2010-12-31 $18
2010-09-30 $18
2010-06-30 $11
2010-03-31 $12
2009-12-31 $13
2009-09-30 $9
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.157B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.480B 32.51
Bruker (BRKR) United States $11.768B 31.38
Kewaunee Scientific (KEQU) United States $0.099B 11.71